KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Amortizatization of Intangibles: 2023-2024

Historic Amortizatization of Intangibles for Nektar Therapeutics (NKTR) over the last 2 years, with Dec 2024 value amounting to -$9.2 million.

  • Nektar Therapeutics' Amortizatization of Intangibles rose 30.57% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year change of. This contributed to the annual value of -$9.2 million for FY2024, which is 37.77% up from last year.
  • According to the latest figures from FY2024, Nektar Therapeutics' Amortizatization of Intangibles is -$9.2 million, which was up 37.77% from -$14.9 million recorded in FY2023.
  • Nektar Therapeutics' Amortizatization of Intangibles' 5-year high stood at -$9.2 million during FY2024, with a 5-year trough of -$14.9 million in FY2023.
  • Over the past 2 years, Nektar Therapeutics' median Amortizatization of Intangibles value was -$12.1 million (recorded in 2023), while the average stood at -$12.1 million.
  • Data for Nektar Therapeutics' Amortizatization of Intangibles shows a peak YoY soared of 37.77% (in 2024) over the last 5 years.
  • Over the past 2 years, Nektar Therapeutics' Amortizatization of Intangibles (Yearly) stood at -$14.9 million in 2023, then surged by 37.77% to -$9.2 million in 2024.